Subscribe free

Newsletter

Surgical Endoscopy

Every new paper in this field, in your inbox.

FreeNo spamOne-click unsubscribe
Am J Gastroenterol19 Oct 2024

Visual endoscopic retrograde appendicitis therapy reduces recurrence risk

Findings indicate that visual endoscopic retrograde appendicitis therapy (v-erat) and antibiotic therapy have similar treatment success rates for uncomplicated acute appendicitis (93.6% vs. 90.5%). However, v-erat significantly lowers the recurrence risk during follow-up and decreases the appendectomy rate (4.3% vs. 9.5%). Additionally, patients undergoing v-erat…

Am J Gastroenterol18 Oct 2024

Identified risk factors for inadequate bowel preparation in colonoscopy

A meta-analysis of 154 studies involving 358,257 participants identified 48 unique risk factors for inadequate bowel preparation (IBP) before colonoscopy. Key sociodemographic predictors included Medicaid insurance, obesity, and male sex, while comorbidities such as psychiatric disease and diabetes also played significant roles. Medication use, particularly…

Therap Adv Gastroenterol17 Oct 2024

Minimally invasive approach effectively treats appendicitis

Endoscopic retrograde appendicitis therapy (ERAT) emerges as a promising alternative for managing acute or chronic appendicitis, allowing effective elimination of obstructions through endoscopic techniques. Compared to antibiotic therapy, patients undergoing ERAT showed lower rates of recurrence and avoided the need for appendectomy. Innovations like the…

BMC Gastroenterol16 Oct 2024

Predictive model established for early esophageal cancer invasion

A logistic regression model developed from various risk factors effectively predicts early esophageal cancer with submucosal infiltration beyond 200 micrometers. Key predictive factors include endoscopic findings, esophageal wall thickening, pickled food intake, platelet-lymphocyte ratio, tumor size, circumferential mucosal defect percentage, and preoperative pathological type. The…

J Gastrointest Surg15 Oct 2024

Minimally invasive common bile duct exploration reduces fluoroscopy time.

In a comparison of minimally invasive common bile duct exploration (MICBDE) and endoscopic retrograde cholangiopancreatography (ERCP) for treating choledocholithiasis, significant advantages were found for MICBDE. Fluoroscopy time was notably lower for MICBDE (1.54 minutes) compared to ERCP (3.1 minutes, p

Surg Endosc11 Oct 2024

Re-examining the entire colon enhances polyp detection rates.

A randomized controlled trial involving 406 patients demonstrated that re-examination of the entire colon significantly improves the detection of concealed polyps and adenomas compared to standard colonoscopic methods. While polyp detection rates were generally similar between the study and control groups, the second withdrawal significantly…

Dig Dis Sci9 Oct 2024

Endoscopic ultrasound effectively diagnoses unexplained bile duct dilation.

Endoscopic ultrasound (EUS) demonstrated significant diagnostic yield for patients with unexplained common bile duct (CBD) dilation, particularly among those with negative prior imaging. In a cohort of 109 patients, 41 tested positive for various conditions, including choledocholithiasis and chronic pancreatitis. Factors such as older age…

Endosc Ultrasound3 Oct 2024

EUS-guided biopsy yields valuable mutation data in pancreatic cancer

A study evaluated the feasibility of EUS-guided fine-needle biopsy (EUS-FNB) for next-generation sequencing (NGS) in unresectable pancreatic ductal adenocarcinoma (PDAC). The technical yield of EUS-FNB met criteria in 48% of cases, while the molecular yield was remarkably high at 98%. This means that nearly all…

J Clin Gastroenterol2 Oct 2024

EUS-BD offers reduced pancreatitis risk compared to ERCP

A systematic review and meta-analysis revealed that endoscopic ultrasound-guided biliary drainage (EUS-BD) is a safe alternative to ERCP transpapillary drainage (ERCP-TPD) for primary biliary drainage in patients with distal malignant biliary obstruction (DMBO). Among 815 patients analyzed, clinical and technical success rates were similar for…

Int J Surg2 Oct 2024

Radiation-emitting stents improve survival in cholangiocarcinoma patients

In a multicenter trial, the use of radiation-emitting metallic stents (REMS) combined with hepatic arterial infusion chemotherapy (HAIC) significantly enhanced overall survival (10.2 months vs. 6.7 months) and time to symptomatic progression (8.6 months vs. 5.4 months) compared to self-expandable metallic stents (SEMS) with HAIC…